Get notified when SNDX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSyndax Pharmaceuticals reports Q4 and full-year fiscal 2026 financial results
Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the quarter and year ended March 31, 2026 via press release and investor presentation. Specific financial metrics are contained in the attached exhibits.
Item 7.01 view on EDGAR → -
low
Filing is procedural in nature, with detailed financial performance data provided in separate press release (Exhibit 99.1) and corporate presentation (Exhibit 99.2) rather than in the 8-K body.
8-K: Exhibits verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade SNDX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify